Table 1.
Escherichia coli | Pseudomonas spp. | Proteus mirabilis | |
---|---|---|---|
Number of Isolates | 100 | 27 | 26 |
Antimicrobial | |||
Amikacin | 99% | 100% | 92% |
Amoxicillin/clavulanic acid | 78% | 4% | 100% |
Ampicillin | 64% | 4% | 84% |
Cefazolin | 79% | 4% | 88% |
Cefovecin | 82% | 7% | 96% |
Cefoxitin | 83% | 4% | 96% |
Cefpodoxime | 82% | 4% | 96% |
Ceftiofur | 79% | 7% | 96% |
Cephalothin ** | 100% | 100% | |
Chloramphenicol | 84% | 4% | 69% |
Clindamycin ¥ | 2% | 4% | 0% |
Doxycycline | 78% | 7% | 0% |
Enrofloxacin | 85% | 70% | 92% |
Erythromycin ¥ | 10% | 4% | 0% |
Gentamycin | 94% | 85% | 85% |
Imipenem | 100% | 100% | 96% |
Marbofloxacin | 83% | 92% | |
Oxacillin + 2%NACL | 0% | 7% | 0% |
Penicillin | 0% | 4% | 0% |
Ticarcillin | 64% | 100% | 85% |
Ticarcillin/clavulanic acid | 75% | 100% | 96% |
Trimethoprim/sulfamethoxazole | 85% | 11% | 85% |
** Number of isolates tested for cephalothin susceptibility were as follows: E. coli = 67, Proteus mirabilis = 20. ¥ indicates the drug is primarily used for Gram-positive organisms. Grey-shading indicates that susceptibility to a drug was not tested with that organism.